✦ LIBER ✦

Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole

✍ Scribed by C. Skedgel; D. Rayson; R. Dewar; T. Younis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial exploring the biomark

✍ O. C. Freedman; E. Amir; W. Hanna; H. Kahn; F. O’Malley; G. Dranitsaris; D. E. C 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 257 KB

Phase III randomized adjuvant study of t

✍ Tomohiko Aihara; Yuichi Takatsuka; Shozo Ohsumi; Kenjiro Aogi; Yasuo Hozumi; Shi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 296 KB

Cost-effectiveness analysis of anastrozo

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB